Senate Finance Committee Chairman Ron Wyden asked Pfizer to provide details on its tax practices to explain how the drug company has consistently paid tax rates that are significantly lower than the corporate tax rate in a letter released by the committee Tuesday.
Wyden Expands Pharma Tax Investigation With Pfizer Inquiry
by usoftax_admin | May 21, 2024 | Tax News